Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CNTX compared with PALI: revenue, margins and what each company keeps, and the suppliers and customers both name
CNTX
Context Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
PALI
Palisade Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CNTX
Context Therapeutics Inc.
vs
PALI
Palisade Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
CNTX
Context Therapeutics Inc.
Change
0.20
▼
−0.55%
· post 0.19
Mkt cap
$17.4M
Revenue
—
PALI
Palisade Bio, Inc.
Change
1.17
▼
−1.97%
· post 1.16
Closed
Oct 30 '26
Mkt cap
$202.2M
Revenue
$500,000
Q2 FY26
vs
Compare
Closed
Oct 30 '26
CNTX
Context Therapeutics Inc.
vs
PALI
Palisade Bio, Inc.
0.20
▼
−0.55%
post 0.19
Price
1.17
▼
−1.97%
post 1.16
$17.4M
Mkt cap
$202.2M
—
Revenue
$500,000
Q2 FY26
Change
Change
CNTX
0.20
▼
−0.55%
vs
PALI
1.17
▼
−1.97%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CNTX, solid
PALI, dashed
Supply-chain overlap
Revenue flow
CNTX: latest quarter not drawable. PALI: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CNTX
6
—
BioAtla, Inc. ("BioAtla")
unlisted
supplier
—
Integral Molecular, Inc. ("Integral")
unlisted
supplier
—
Just-Evotec Biologics
unlisted
supplier
—
Link (assignment for the benefit of creditors), LLC ("Link")
unlisted
supplier
2 more · CNTX chain
›
Shared
0
No shared counterparties.
Only PALI
2
—
Giiant Pharma
unlisted
supplier
—
Newsoara
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR